Target intelligence / Profile preview

Antioxidant and detoxification enzymes

Molecular classification
Enzyme, Oxidoreductase, Transferase
01

Overview

Antioxidant and detoxification enzymes are a collective group of proteins essential for maintaining cellular integrity against oxidative and chemical insults. This group includes primary antioxidant enzymes like superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), which neutralize reactive oxygen species (ROS), as well as Phase II detoxification enzymes such as glutathione S-transferases (GSTs) and NAD(P)H:quinone oxidoreductase 1 (NQO1) [1, 2]. These enzymes are coordinately regulated by the transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2), which translocates to the nucleus under stress conditions to bind the Antioxidant Response Element (ARE) in the promoter regions of these genes [2]. Dysregulation of this system is implicated in a wide range of pathologies, including neurodegenerative diseases, chronic inflammation, and cancer, where oxidative damage drives disease progression [3]. Pharmacological modulation typically involves Nrf2 activators, such as dimethyl fumarate and omaveloxolone, which enhance the expression of these enzymes to provide cytoprotection [4, 5]. However, the therapeutic window must be carefully managed, as over-expression of these enzymes in cancer cells can lead to drug resistance and tumor survival [1].

Other names
Phase II detoxifying enzymesCytoprotective enzymesARE-regulated enzymesRedox-regulating enzymesAntioxidant response element-regulated enzymes
02

Mechanism of action

Induction of gene expression via the Nrf2/ARE signaling pathway [1, 2]; direct enzymatic neutralization of reactive oxygen species [3]; conjugation of electrophilic xenobiotics with glutathione [2].

03

Biological functions

Redox homeostasisXenobiotic metabolismDetoxificationResponse to oxidative stressCellular protection
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseChronic kidney diseaseDiabetes mellitus
05

Safety considerations

Promotion of chemoresistance in established tumors [1]Cardiovascular risks such as fluid retention (e.g., bardoxolone methyl) [4]Potential for pro-oxidant activity at high concentrationsOff-target effects of electrophilic Nrf2 activators
06

Interacting drugs

Dimethyl fumarate

6 more in the full profile.

07

Biomarkers

NAD(P)H:quinone oxidoreductase 1 (NQO1) levelsHeme oxygenase-1 (HO-1) expressionGlutathione (GSH) concentrationMalondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Antioxidant and detoxification enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxidant and detoxification enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call